Related Experiment Video

Updated: Jun 24, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

[Cellular and molecular deregulations driving the metastatic phenotype]

Guy Zeitoun1

  • 1Service de Chirurgie générale et digestive, Centre Hospitalier François Quesnay, 2, boulevard Sully, 78200 Mantes-la-Jolie, France. g.zeitoun@ch-mantes-la-jolie.fr

Medecine Sciences : M/S
|April 14, 2009
PubMed

Insights

DNA instability initiates cancer by altering stem cells, with chromosomal instability frequently seen in colon adenocarcinoma. Specific APC mutations drive WNT pathway deregulation, enabling cancer cell migration and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Cancerogenesis originates from DNA instability affecting stem cells.
  • Organ-specific regulation involves morphogenetic factors.
  • DNA instability manifests as chromosomal aberrations or replication errors.

Purpose:

  • To explore the role of DNA instability in cancerogenesis.
  • To investigate the link between chromosomal instability and colon adenocarcinoma metastasis.
  • To understand how APC mutations influence WNT pathway and cancer cell migration.

Summary:

  • Chromosomal instability is a hallmark of colon adenocarcinoma, present even in metastatic sites.
  • Somatic APC mutations disrupt the WNT pathway, correlating with mutation position and cancer cell migration.
  • This deregulation facilitates stem cell metastasis and expansion within the host organ.

Impact:

  • Highlights the critical role of DNA instability and APC mutations in colon cancer progression.
  • Provides insights into the mechanisms of cancer cell metastasis.
  • Informs potential therapeutic strategies targeting WNT pathway and stem cell behavior.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...